Thank you for joining the call today.
This Work Group operates under the Non-Assertion Covenant IPR option found as an appendix to IPR Policies V2.0 that Kantara operates.The Group Participation Agreement memorializes your acknowledgment of the terms under which you participate in this Work Group. Every person who has acknowledged the GPA is listed in the Participant Roster, as a voting or non-voting participant.However, there are circumstances, such as in-person workshops or calls where non-participant guests may be present who have not acknowledged the GPA for this Work Group.
Every person on this call is strongly encouraged to acknowledge the GPA for this Work Group prior to any form of participation.
If you have not, or do not wish to, please Note Well the following before you participate in any form.
Again, if you are uncertain about any matters, please remain silent and do not contribute anything in writing.
it is a simple as presenting the specified categories for Medical research (from GA4GH) so that they can be mapped with the DPV, and then presented back to that W3C list for comment.
But, this does bring up a lot of questions we should conside, and we should definitely confirm what the objective is before we start.
Are we looking to be able to specify the same explicit consent research with DUO, but with the DPV?
Can we use the privacy agreement to specify the consent for genomic research ? -
would be usable in the GA4GH ecosystem ?
Should it be a DLC reference implementation, with a review of the Privacy Agreement for Common Accord, and perhaps a round of feedback from key stakeholders?